Influence of atenolol on coronary artery spasm after acute myocardial infarction in a Japanese population

International Journal of Cardiology

Volumn 139, Issue 2, 2010, Pages 181-186

  Shirotani, Manabu ^a   Yokota, Ryoji ^a   Kouchi, Ichiro ^a   Hirai, Taku ^a   Uemori, Noritsugu ^a   Haba, Kazunao ^a   Hattori, Ryuichi ^a  

^a KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Beta blocker; Coronary spasm; Japanese

Indexed keywords

ATENOLOL; ERGOMETRINE;

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEMODYNAMICS; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASIAN CONTINENTAL ANCESTRY GROUP; ATENOLOL; COHORT STUDIES; CORONARY VASOSPASM; ERGONOVINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77249087285     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.017     Document Type: Article

References (23)

1. Jafri S.M., Khaja F., McFarland T., et al. Efficacy of propranolol therapy after acute myocardial infarction related to coronary anatomy and left ventricular function. Am J Cardiol 60 (1987) 976-980
2. Kernis S.J., Harjai K.J., Stone G.W., et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?. J Am Coll Cardiol 43 (2004) 1773-1779
3. Ishikawa K., Miyataka M., Kimura A., et al. Beta-blockers prevent cardiac events in Japanese patients with myocardial infarction. Circ J 68 (2004) 59-67
4. Wienbergen H., Zeymer U., Gitt A.K., et al. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction. Am J Cardiol 99 (2007) 1208-1211
5. Basu S., Senior R., Raval U., van der Does R., Bruckner T., and Lahiri A. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. Circulation 96 (1997) 183-191
6. Poulsen S.H., Jensen S.E., and Egstrup K. Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction. Am Heart J 138 (1999) 710-720
7. Senior R., Basu S., Kinsey C., Schaeffer S., and Lahiri A. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J 137 (1999) 646-652
8. Pristipino C., Beltrame J.F., Finocchiaro M.L., et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101 (2000) 1102-1108
9. The Japanese Beta-blockers and Calcium Antagonists Myocardial Infarction (JBCMI) investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 93 (2004) 969-973
10. Robertson R.M., Wood A.J.J., Vaughn W.K., and Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 65 (1982) 281-285
11. Tilmant P.Y., Lablanche J.M., Francois A., Thieuleux A., Dupuis B.A., and Bertrand M.E. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol 52 (1983) 230-233
12. Beltrame J.F., Sasayama S., and Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 (1999) 1442-1452
13. Mongiardo R., Finocchiaro M.L., Beltrame J., et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol 78 (1996) 84-87
14. Nikolaou K., Knez A., Rist C., et al. Accuracy of 64-MDCT in the diagnosis of ischemic heart disease. Am J Roentgenol 187 (2006) 111-117
15. Leber A.W., Knez A., von Ziegler F., et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 46 (2005) 147-154
16. Sueda S., Ochi N., Kawada H., et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 83 (1999) 1186-1190
17. Sueda S., Kohno H., Fukuda H., et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 55 (2004) 403-411
18. Suzuki Y., Tokunaga S., Ikeguchi S., et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J 124 (1992) 39-47
19. Svendsen T.L. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity. J Cardiovasc Pharmacol 5 Suppl 1 (1983) S21-25
20. Frishman W.H. Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drug. Am J Cardiol 59 (1987) 33F-37F
21. Kazanietz M.G., and Enero M.A. Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol. J Pharmacol Exp Ther 252 (1990) 758-764
22. Pfisterer M., Cox J.L., Granger C.B., et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 32 (1998) 634-640
23. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150